The Full Spectrum of News.
Get Started
SubscribeLogin
Champions League
Paris Saint-Germain
Baseball
NCAA
Israel-Hamas Conflict
Natural Disasters
Social Media
Soccer
Netflix
Artificial Intelligence
Home Run
New York Knicks
Published • loading... • Updated

As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs

Summary by STAT
FDA, NIH push to reduce or replace animal testing expected to spur growth in organoid firms; Dan Huh's Vivodyne announces $40 million investment.

1 Articles

All
Left
Center
1
Right
STATSTAT
Center

As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs

FDA, NIH push to reduce or replace animal testing expected to spur growth in organoid firms; Dan Huh's Vivodyne announces $40 million investment.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Thursday, May 29, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups

Startups

Animal Testing

Animal Testing

iPhone

iPhone

Boston, Massachusetts

Boston, Massachusetts

News
For You
SearchBlindspotLocal